Filing Flows › Abeona Therapeutics (ABEO) › Q2 2025
Abeona Therapeutics (ABEO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Abeona Therapeutics (ABEO) reported revenue of $400K for the second quarter 2025 (Q2 2025).
Abeona Therapeutics, Q2 2025: revenue $400K, net earnings $109M, operating cash flow −$18.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $400K | — | — |
| Operating profit | −$22.8M | — | — |
| Net earnings | $109M | — | — |
| Operating cash flow | −$18.8M | — | — |
What changed
Revenue was $400K in Q2 2025.
Operating costs exceeded revenue by $22.8M, an operating margin of -5698.0%. Net earnings were $108.8M. The effective tax rate was 12.5%. Non-operating items added $147.1M, 118% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$18.8M. Non-cash charges added back $544K of depreciation and amortization and $2.8M of share-based compensation. Working capital and other items used $131.0M. Capital expenditures of $2.9M exceeded it, leaving free cash flow of −$21.7M.
Questions
What was Abeona Therapeutics' revenue in the second quarter 2025?
Abeona Therapeutics (ABEO) reported revenue of $400K for the second quarter 2025 (Q2 2025).